about
Summary 2015 ESC guidelinesWill oral antithrombin agents replace warfarin?Automatic segmentation of in-vivo intra-coronary optical coherence tomography images to assess stent strut apposition and coverage.Thrombolytic therapy. State of the art.EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.Tremor mimicking ventricular tachycardia.Genetics and coronary artery disease.Acute ST-elevation myocardial infarction.New oral anticoagulant agents after ACS.Low MT-CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease.Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation.Routine invasive versus conservative management in non-ST-elevation acute coronary syndromes.Generic atorvastatin, the Belgian statin market and the cost-effectiveness of statin therapy.Patient co-payment and adherence to statins: a review and case studies.The apical nipple sign: a useful tool for discriminating between anterior infarction and transient left ventricular ballooning syndrome.From therapeutic hypothermia towards targeted temperature management: a decade of evolution.Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary InterventionOptical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised cResults of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension.Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.γδ T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort study.Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: findings from the EPICOR study.Mode of admission and its effect on adherence to reperfusion therapy guidelines in Belgian STEMI patients.[Therapeutic hypothermia: effects beyond neuroprotection].Editor's Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association.Air pollution and ST-elevation myocardial infarction: A case-crossover study of the Belgian STEMI registry 2009-2013.Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.Oral antiplatelet therapy in acute coronary syndromes: update 2012.Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluatiGender, TIMI risk score and in-hospital mortality in STEMI patients undergoing primary PCI: results from the Belgian STEMI registry.Preexisting antiadenoviral immunity and regional myocardial gene transfer: modulation by nitric oxide.Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.Value of cardiovascular magnetic resonance in patients with suspected inflammatory pericarditis.Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis.Transporting STEMI patients for primary PCI: a long and winding road paved with good intentions?Managing acute coronary syndrome caused by plaque erosion without stent implantation: a word of caution.Key interventions and quality indicators for quality improvement of STEMI care: a RAND Delphi survey.Time course of electrocardiographic changes in transient left ventricular ballooning syndrome.Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
P50
Q26768504-2E405F5E-CE2D-454F-B243-15B1F0191A30Q28208671-29C5AB95-9A28-4116-8E73-F2828DD51B9AQ34166587-224DB3B4-8316-4C9D-99E8-122B5F1AAB8AQ34376952-4F811C27-5342-40FF-9975-EC193527FBC1Q34651036-B9900E20-E7BE-4769-9C61-AD0DDE804B61Q35847125-EC999F54-1D1A-450C-BF06-26D94BD1AB05Q36001618-550628D5-84AE-43FB-BFAC-FA6AD9A44526Q36714323-36DFC17C-36BD-4CF8-AC02-6AF9E1774FADQ37140964-095B9C43-0F14-4D84-9197-471BB9F156CFQ37556409-57BD6BA7-EC4D-40CF-A6EA-0E897085851BQ37945342-78200B24-5311-42A2-877D-5D29CE3875D4Q37951403-2CF02619-9030-4F94-B9EF-76926B8F9124Q38067640-1D1D70D1-13F9-4A1E-91EA-D02FC8D450D6Q38154826-989B9A86-7234-4E1E-B462-A4DFA29AA218Q38174999-A519ECF7-2BCF-49F6-B81B-1940F5C79374Q38271143-8AA7B3CD-0198-4E76-A869-04A96C907374Q38372507-145FCF4C-CB1B-420A-8E54-D461FD482DAAQ38425203-5E52777D-F34C-45B9-99F2-36CEACB6961EQ38685633-0F957D83-6DAF-4CC6-B03B-3A94A143075DQ38724104-D4F63F6B-5223-4ACA-8A62-52EA78489B1AQ38885316-16EFEFAE-E4E0-423A-8C04-25D2C531FACAQ38999087-C1BCE784-5B98-4CFF-9CB8-F95F5DF1C770Q39468209-5C649041-0AC2-43CC-9B3B-EFAC34F41E7AQ39793117-368105AC-C29E-4853-B47A-9395F4299F84Q40191863-7D285684-CF2C-4665-A058-7C40C2630E48Q40238674-6988DA4E-F414-4844-A8D1-1DB1B8BBAFC7Q40615212-93F9AEE7-F066-4422-A050-A77A7D04CC4FQ40886104-8546A298-89E2-451D-93C2-517C584531D5Q42185272-5EF6A8A0-AC8C-42E7-AD13-82B25A584C6FQ43701410-2DE2958C-E0CF-47EC-A3C4-11E431A787D2Q44944937-92249E26-E72F-4941-8B91-0E9B28C3318FQ45858017-705185F6-E076-43E5-B239-EE5ABAE16FD9Q45871479-2244A355-0D37-4667-B8F9-941C021D71D3Q46807223-75A30EEE-D358-4B3E-9637-8AF59346AEC7Q47185843-8AFC5B7E-14AC-4EB3-96E4-02A0880EAB8CQ47587363-A04D5C65-0014-422E-9E50-180EF9463B45Q48088898-202953C0-A04B-4AA8-AE87-C3764FE9F7B1Q48123359-0BE08970-3815-45AC-BD48-C448672D9813Q48422323-3C16842D-F6FF-4635-9EFB-17C9C6497FFEQ48611685-93BB6975-0D22-4CBE-B721-1289530684C1
P50
description
researcher
@en
wetenschapper
@nl
name
Peter Sinnaeve
@en
Sinnaeve P
@nl
type
label
Peter Sinnaeve
@en
Sinnaeve P
@nl
altLabel
Sinnaeve P
@en
prefLabel
Peter Sinnaeve
@en
Sinnaeve P
@nl
P106
P108
P31
P496
0000-0003-4716-5892